217 related articles for article (PubMed ID: 32601104)
41. MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors.
Dluzen DF; Lazarus P
Drug Metab Rev; 2015 Aug; 47(3):320-34. PubMed ID: 26300547
[TBL] [Abstract][Full Text] [Related]
42. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review.
Raju B; Choudhary S; Narendra G; Verma H; Silakari O
Drug Metab Rev; 2021 Feb; 53(1):45-75. PubMed ID: 33535824
[TBL] [Abstract][Full Text] [Related]
43. Current knowledge of microRNA-mediated regulation of drug metabolism in humans.
Nakano M; Nakajima M
Expert Opin Drug Metab Toxicol; 2018 May; 14(5):493-504. PubMed ID: 29718737
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
45. Modulating epigenetic modifications for cancer therapy (Review).
Castro-Muñoz LJ; Ulloa EV; Sahlgren C; Lizano M; De La Cruz-Hernández E; Contreras-Paredes A
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799181
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic Regulation in Kidney Toxicity: Insights From Cisplatin Nephrotoxicity.
Xiang X; Guo C; Tang C; Cai J; Dong Z
Semin Nephrol; 2019 Mar; 39(2):152-158. PubMed ID: 30827338
[TBL] [Abstract][Full Text] [Related]
47. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms.
Stanzione R; Cotugno M; Bianchi F; Marchitti S; Forte M; Volpe M; Rubattu S
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31941075
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic alterations and cancer: new targets for therapy.
Allen A
IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic Alterations in Bladder Cancer.
Porten SP
Curr Urol Rep; 2018 Oct; 19(12):102. PubMed ID: 30357502
[TBL] [Abstract][Full Text] [Related]
50. Cancer's epigenetic drugs: where are they in the cancer medicines?
Ghasemi S
Pharmacogenomics J; 2020 Jun; 20(3):367-379. PubMed ID: 31819161
[TBL] [Abstract][Full Text] [Related]
51. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it.
Verma H; Singh Bahia M; Choudhary S; Kumar Singh P; Silakari O
Drug Metab Rev; 2019 May; 51(2):196-223. PubMed ID: 31203662
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic agents in combined anticancer therapy.
Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
[TBL] [Abstract][Full Text] [Related]
54. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
56. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
Pajares MJ; Alemany-Cosme E; Goñi S; Bandres E; Palanca-Ballester C; Sandoval J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298969
[TBL] [Abstract][Full Text] [Related]
58. DNA methylation and personalized medicine.
Tang J; Xiong Y; Zhou HH; Chen XP
J Clin Pharm Ther; 2014 Dec; 39(6):621-7. PubMed ID: 25230364
[TBL] [Abstract][Full Text] [Related]
59. Unraveling the epigenetic code of cancer for therapy.
Smith LT; Otterson GA; Plass C
Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
[TBL] [Abstract][Full Text] [Related]
60. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
